title: Selective repopulation of mice liver after Fas-resistant hepatocyte transplantation.
abstract: Hepatocyte transplantation has been proposed as a potential therapeutic method to treat irreversible liver failure and inherited hepatic disorders, although transplanted cells do not easily reconstruct the liver tissue under intact conditions. This study was aimed at modulating the recipient liver conditions to promote repopulation of the liver after hepatocyte transplantation. Hepatocytes isolated from male MRL-lpr/lpr (lpr) mice with a mutation of Fas antigen were transplanted in a number of 1 x 10(6) cells in female MRL-+/+ (wild-type mice) by intrasplenic injection. An agonistic anti-Fas antibody (0.15 mg/kg) was administered intravenously 24 h after cell transplantation. We also administrated the antibody at 0.3 mg/kg 1 week after grafting and at 0.6 mg/kg 2 weeks after transplantation. The liver specimens were taken at different time intervals for histological examination. The reconstructed male lpr hepatocytes in the female wild-type mice were determined by a real-time quantitative PCR assay using the primers and probe for the sry gene. The pathologic findings of the recipient livers after treatment with anti-Fas antibody revealed a large number of apoptotic hepatocytes. The grafted lpr hepatocytes were observed to reconstruct as much as 6.9% of the recipient liver in the anti-Fas antibody-treated group 3 months after transplantation. In contrast, we observed the transplanted cells at lower than 0.1% in the nontreated livers. These findings demonstrated that repeated induction of apoptosis in recipient hepatocytes shifts the environment of the liver to a regenerative condition. This method may be useful to promote the reconstruction of transplanted hepatocytes in a recipient liver.
authors.affiliation: Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Fujino
authors.forename: X K
authors.initials: XK
authors.lastname: Li
authors.forename: Y
authors.initials: Y
authors.lastname: Kitazawa
authors.forename: N
authors.initials: N
authors.lastname: Funeshima
authors.forename: L
authors.initials: L
authors.lastname: Guo
authors.forename: T
authors.initials: T
authors.lastname: Okuyama
authors.forename: T
authors.initials: T
authors.lastname: Amano
authors.forename: H
authors.initials: H
authors.lastname: Amemiya
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
mesh_terms: D000818:Animals; D000906:Antibodies / Q000378:metabolism; D017209:Apoptosis; D001219:Aspartate Aminotransferases / Q000097:blood; D001483:Base Sequence; D005260:Female; D024282:Genes, sry; D022781:Hepatocytes / Q000378:metabolism* / Q000637:transplantation*; D006801:Humans; D020287:In Situ Nick-End Labeling; D008099:Liver / Q000166:cytology / Q000502:physiology*; D008115:Liver Regeneration; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction / Q000295:instrumentation / Q000379:methods; D018183:Transplantation Chimera; D019014:fas Receptor / Q000235:genetics / Q000502:physiology*
chemical_list: D000906:Antibodies; D019014:fas Receptor; D001219:Aspartate Aminotransferases